Harmony Biosciences Holdings, Inc.
HRMY · NASDAQ
Bulios Fair Price
$58.84
40.0% upside
Trenutna cena
$42.02
Po podatkih Bulios Fair Price je delnica HRMY trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Harmony Biosciences Holdings, Inc. (HRMY) is an American company specializing in research, development, and commercialization of drugs and therapies for sleep disorders and neurological conditions. With activities in biotechnology and pharmaceuticals, Harmony Biosciences Holdings is a key player in the world of sleep disorder and neurological condition treatment. Their research focuses on innovative treatment approaches and therapies for various sleep disorders, such as narcolepsy. The company aims to improve the lives of patients suffering from these conditions and provide modern treatment solutions. Harmony Biosciences Holdings is characterized by expertise in neurology and the treatment of sleep disorders. Harmony Biosciences Holdings, Inc. (HRMY) shares could be suitable for investors looking for an investment opportunity in the biotechnology and pharmaceutical sector with a company focused on innovations in the treatment of sleep disorders and neurological conditions and enhancing the quality of life for patients.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Jeffrey Dayno
Employees
293
Headquarters
Plymouth Meeting
Prihajajoči dogodki
Earnings
Upcoming earnings report